방법 비교
선택한 방법을 나란히 검토하세요. 서로 다른 행은 강조 표시됩니다.
| 비부비동 결과 검사-22× | 만성 호흡기 질환 설문지× | |
|---|---|---|
| 분야 | 호흡기학 | 호흡기학 |
| 계열 | Process / pipeline | Process / pipeline |
| 기원 연도≠ | 2009 | 1987 |
| 창시자≠ | Claire Hopkins, King's College London | Gordon H. Guyatt, McMaster University |
| 유형≠ | Self-report questionnaire | Self-report or interviewer-administered questionnaire |
| 원전≠ | Hopkins, C., Gillett, S., Slack, R., Lund, V. J., & Browne, J. P. (2009). Psychometric validity of the 22-item Sinonasal Outcome Test. Clinical Otolaryngology, 34(5), 447-454. DOI ↗ | Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987). A measure of quality of life for clinical trials in chronic lung disease. Thorax, 42(10), 773-778. DOI ↗ |
| 별칭 | SNOT-22, SNOT | CRQ, Chronic Respiratory Q |
| 관련 | 5 | 5 |
| 요약≠ | The SNOT-22 is a 22-item disease-specific quality-of-life questionnaire designed to assess sino-nasal symptoms and their functional impact on patients with chronic rhinosinusitis, nasal polyposis, and allied conditions. Developed by Hopkins and colleagues at King's College London in 2009, it has become the most widely used instrument for measuring sino-nasal disease burden in clinical trials and rhinological practice. The SNOT-22 provides rapid, patient-centered assessment of both nasal-specific symptoms (congestion, drainage, sneezing) and general health impacts (sleep, headache, concentration). | The CRQ is a 20-item, four-domain questionnaire developed by Guyatt and colleagues at McMaster University in 1987 to measure health-related quality of life specifically in patients with chronic respiratory disease, particularly chronic obstructive pulmonary disease and cystic fibrosis. Uniquely, the CRQ can be administered by interview or self-report, and its four domains (dyspnea, fatigue, emotional function, mastery) directly address the multidimensional burden of chronic respiratory disease. The CRQ has demonstrated exceptional responsiveness to pulmonary rehabilitation and other interventions, making it a preferred outcome measure in respiratory research and clinical practice. |
| ScholarGate데이터셋 ↗ |
|
|